Loading…
Hosted by Osmind · 🇺🇸 US · EN · 33 episodes
Established thought leaders with verified media credentials.
Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future. Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more.Join us on this thrilling journey, and let’s transform mental health together.
Osmind hosts Psychiatry Tomorrow, a health show with 33 episodes published.
Dr. Anita Clayton, chair of psychiatry at UVA and a former Navy physician, built the CSFQ — the validated scale now used across specialties to measure antidepressant sexual dysfunction — after noticing her fluoxetine pat
The FDA cleared TMS for depression in 2008, yet by one estimate fewer than 1% of the patients who would qualify for it ever get treated. Dr. Will Sauvé sits down with Dr. Scott West, the psychiatrist who brought TMS to T
Ben Leopold spent years on 10 different antidepressants, each one trading his lowest lows for a flatline existence that erased his personality. It wasn't until a psychiatrist stopped prescribing and started digging into
Most of Brittany Albright's treatment-resistant depression patients test positive for obstructive sleep apnea. Some longstanding ADHD cases turn out to be sleep apnea too—treated, the diagnosis comes off. Dr. Avinesh Bha
What if one of psychiatry's most effective treatments for treatment-resistant depression emerged from watching childbirth breathing techniques? Around 30-48% of depression patients become treatment-resistant after failin
Nine out of twenty patients in Dr. Brittany Albright's psychiatry practice were taking GLP-1 medications—not for weight loss, but because metabolic and psychiatric disease share the same pathophysiology. About 43% of pat
Dr. Martha Koo bought her first TMS machine in 2009 when colleagues thought she was "crazy"—now she runs 11 centers across California as immediate past president of the Clinical TMS Society. Her biggest revelation came w
Summary Dr. Nicholas Fabiano, a third-year psychiatry resident at the University of Ottawa with 70,000+ X followers, explains how exercise can match antidepressants for mild-to-moderate depression through muscle-released
After a young patient died by suicide, many psychiatrists might retreat to safer cases—Dr. Matt Bernstein took a different path, choosing to treat our field's highest-risk patients in their communities rather than behind
Dr. Husseini K. Manji takes us behind the scenes of esketamine's development, from basic neuroscience research to FDA approval. Learn about the science of targeting NMDA receptors, the rigorous clinical trial process, an
Charles Miller, CRNA, founder of Scenic City Neurotherapy, takes us through his journey of starting a ketamine infusion therapy clinic from scratch. From cashing out his 401k to navigating complex licensing requirements,
In this episode of Psychiatry Tomorrow, Dr. Carlene MacMillan hosts a panel of experts to discuss the FDA's pending decision on MDMA-assisted therapy for PTSD. The conversation explores the current landscape of clinical
In this captivating episode, we explore Dr. David Feifel's unconventional journey from quantum physics to pioneering psychiatrist. Dr. Feifel shares how his fascination with consciousness led him to psychiatry, hoping to
Explore the emerging field of metabolic psychiatry and its potential to revolutionize mental health treatment. Discover the inspiring story of the Baszucki family and how a ketogenic diet helped their son overcome severe
In this episode of Psychiatry Tomorrow, Dr. Jake Behrens shares his insights on navigating the complexities of diagnosing and treating adult ADHD. He discusses his comprehensive framework for ADHD assessments, the import
Dr. Rebecca Allen, a pioneering interventional psychiatrist and president of the Clinical TMS Society, is transforming mental health care delivery through her innovative outpatient clinic in Seattle. By offering a wide r
Legal experts Daniel Sternthal and Ethan Minkin explore the legal intricacies surrounding ketamine therapy for psychiatric conditions. They delve into the importance of interdisciplinary respect, the legal challenges and
Dr. Bergina Isbell, CMO at Led Life Psychiatry, Maryland, combines personal experience and professional innovation to enhance mental health care. Specializing in Ketamine-Assisted Psychotherapy, she offers hope to those
Explore the dynamic landscape of psychiatric clinical trials through the expert lens of Dr. Michael Banov, a renowned figure with a wealth of experience in over 150 trials. This in-depth blog post delves into his groundb
The power of community and networking in private practice psychiatry cannot be overstated. Clinicians often grapple with isolation while staying up-to-date on research, best practices, finding mentors, and collaborative
Scott West
Chief Medical Officer · Nashville Neurocare Therapy
1 appearance on this show
Dr. Nicholas Fabiano
psychiatry resident · University of Ottawa
1 appearance on this show
Dr Matthew Bernstein
Dr.
1 appearance on this show
Dr. Georgia Ede
MD, psychiatrist, nutritional psychiatry expert · Harvard
1 appearance on this show
Dr. Bret Scher
cardiologist and metabolic health expert · Metabolic Mind
1 appearance on this show
Rebecca Allen
Career Success Coach & Personal Brand Specialist for Corporate Women · Lansing Community College
1 appearance on this show
Awais Aftab
Clinical Assistant Professor of Psychiatry · Case Western Reserve University
1 appearance on this show
Avinesh Bhar
Sliiip
1 appearance on this show
Lucian Manu
Stony Brook University
1 appearance on this show
Martha Koo, MD
Clinical TMS Society
1 appearance on this show
Charles Miller
Scenic City Neurotherapy
1 appearance on this show
Dr. David Feifel
UC San Diego
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Psychiatry Tomorrow has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Psychiatry Tomorrow is hosted by Osmind. The show is categorised under health (fitness) and has published 33 episodes.
Psychiatry Tomorrow has published 33 episodes.
Psychiatry Tomorrow regularly covers health, fitness, mental. It sits in the health category, with a fitness focus.
Psychiatry Tomorrow is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Psychiatry Tomorrow hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Psychiatry Tomorrow average 48 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Psychiatry Tomorrow's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.